T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.69% |
| 2 | Consumer Discretionary | 15.01% |
| 3 | Financials | 13.64% |
| 4 | Technology | 12.55% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AET
26
DELISTED
Aetna Inc
AET
| $3.3B | 0.7% |
29,330,165
+10,120,164
| +53% | +$1.08B |
|
27
JPMorgan Chase
JPM
$962B
| $3.29B | 0.7% |
55,488,304
-1,969,345
| -3% | -$115M |
|
28
American Tower
AMT
$79B
| $3.23B | 0.69% |
31,522,276
-2,759,584
| -8% | -$258M |
|
29
Salesforce
CRM
$162B
| $3.04B | 0.65% |
41,233,810
+10,547,719
| +34% | +$726M |
|
|
FISV
30
Fiserv Inc
FISV
$28B
| $2.84B | 0.61% |
55,456,720
-7,049,734
| -11% | -$334M |
|
31
AutoZone
AZO
$49.7B
| $2.72B | 0.58% |
3,409,070
-172,850
| -5% | -$131M |
|
32
ExxonMobil
XOM
$657B
| $2.62B | 0.56% |
31,318,344
-3,445,582
| -10% | -$276M |
|
33
Intercontinental Exchange
ICE
$84.9B
| $2.51B | 0.54% |
53,295,245
-13,200
| -0% | -$642K |
|
|
34
Gilead Sciences
GILD
$168B
| $2.49B | 0.53% |
27,083,581
-12,143,707
| -31% | -$1.1B |
|
35
Roper Technologies
ROP
$39.5B
| $2.46B | 0.53% |
13,483,591
-1,183,066
| -8% | -$204M |
|
36
Becton Dickinson
BDX
$49.4B
| $2.39B | 0.51% |
16,127,563
-1,225,455
| -7% | -$174M |
|
37
PG&E
PCG
$38.1B
| $2.37B | 0.51% |
39,654,356
-5,049,787
| -11% | -$281M |
|
|
BNY
38
Bank of New York Mellon
BNY
$109B
| $2.27B | 0.49% |
61,698,542
+4,785,399
| +8% | +$174M |
|
|
39
NXP Semiconductors
NXPI
$59.6B
| $2.24B | 0.48% |
27,581,859
+18,233,230
| +195% | +$1.36B |
|
|
CELG
40
DELISTED
Celgene Corp
CELG
| $2.18B | 0.47% |
21,798,524
-4,477,414
| -17% | -$461M |
|
|
WBA
41
DELISTED
Walgreens Boots Alliance
WBA
| $2.13B | 0.46% |
25,336,346
+3,979,670
| +19% | +$318M |
|
42
Biogen
BIIB
$30.1B
| $2.11B | 0.45% |
8,119,909
+1,759,477
| +28% | +$465M |
|
43
Humana
HUM
$44.8B
| $2.06B | 0.44% |
11,246,667
+1,633,372
| +17% | +$283M |
|
44
Comcast
CMCSA
$91B
| $2B | 0.43% |
65,650,180
+5,630,142
| +9% | +$162M |
|
45
Vertex Pharmaceuticals
VRTX
$134B
| $1.99B | 0.42% |
25,008,493
+6,185,022
| +33% | +$559M |
|
46
Johnson & Johnson
JNJ
$626B
| $1.96B | 0.42% |
18,157,199
-1,123,860
| -6% | -$116M |
|
47
McKesson
MCK
$105B
| $1.94B | 0.41% |
12,318,088
-2,927,662
| -19% | -$473M |
|
48
Cigna
CI
$72.4B
| $1.93B | 0.41% |
14,048,137
+1,264,724
| +10% | +$174M |
|
|
AMTD
49
DELISTED
TD Ameritrade Holding Corp
AMTD
| $1.89B | 0.4% |
60,043,954
+11,565,680
| +24% | +$341M |
|
50
Citigroup
C
$228B
| $1.86B | 0.4% |
44,564,735
+848,822
| +2% | +$35.5M |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.